Tobacco smoking is the single most preventable cause of death in the United States today. Oncologists are in a unique position to affect the health and economic burdens of smoking by encouraging cessation among their patients who smoke.
Methods
The authors describe and review the effectiveness of current smoking cessation interventions as well as strategies that can be used to encourage cessation among patients. Three types of smoking cessation interventions are described: minimal (or self-help) interventions, behavioral interventions, and pharmacotherapy. The effectiveness of combinations of these types of treatments is also discussed.
Results
Oncology professionals can improve their patients’ chances for success by implementing various cost-effective and easily executed smoking cessation interventions. Advice from a physician to quit smoking has resulted in long-term quit rates of up to 10.2%, and nicotine transdermal patches, nicotine gum, inhalers, and nasal sprays are also effective.
Conclusions
Oncologists are encouraged to adopt the “4As” treatment protocol recommended by the National Cancer Institute: ask patients about their smoking status, advise them to quit, assist by recommending pharmacotherapy, counseling, and psychosocial self-help materials, and arrange follow-up.
References
1.
Centers for Disease Control and Prevention.Cigarette smoking — attributable mortality and years of potential life lost — United States, 1990. MMWR Morb Mortal Wkly Rep.1993; 42: 645–649.
2.
American Cancer Society.Cancer Facts and Figures, 1998: Tobacco Use.Atlanta, Ga: American Cancer Society; 1998.
3.
SiemiatyckiJ., KrewskiD., FrancoE.Associations between cigarette smoking and each of 21 types of cancer: a multisite case-control study. Int J Epidemiol.1995; 24: 504–514.
4.
ThunM.J., Day-LallyC.A., CalleE.E.Excess mortality among cigarette smokers: changes in a 20-year interval. Am J Public Health.1995; 85: 1223–1230.
5.
HarrasA., EdwardsB.K., BlotW.J., eds. Cancer Rates and Risks.4th ed.Bethesda, Md: Cancer Statistics Branch, Division of Cancer Prevention and Control, National Cancer Institute, US Dept of Health and Human Services, Public Health Service; 1996. National Cancer Institute NIH Publication No. (NCI) 96–691.
6.
Centers for Disease Control and Prevention.Medical care expenditures attributable to cigarette smoking — United States, 1993. MMWR Morb Mortal Wkly Rep.1994; 43: 469–472.
7.
US Office on Smoking and Health.The Health Benefits of Smoking Cessation.Rockville, Md: US Dept of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1990. DHHS Publication No. (CDC) 90–8416.
8.
RichardsonG.E., TuckerM.A., VenzonD.J.Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med.1993; 119: 383–390.
9.
Centers for Disease Control.Cigarette smoking among adults — United States, 1994. MMWR Morb Mortal Wkly Rep.1996; 45: 588–590.
10.
The Health Consequences of Smoking: Nicotine Addiction. A report of the Surgeon General.Rockville, Md: US Dept of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Health Promotion and Education, Office on Smoking and Health National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 1988.
11.
KvizF.J., ClarkM.A., HopeH.Patients’ perceptions of their physician's role in smoking cessation by age and readiness to stop smoking. Prev Med.1997; 26: 340–349.
12.
OckeneJ.K.Smoking intervention: the expanding role of the physician. Am J Public Health.1987; 77: 782–783.
13.
PedersonL.L.Compliance with physician advice to quit smoking: a review of the literature. Prev Med.1982; 11: 71–84.
14.
RichmondR.L.Physicians can make a difference with smokers: evidence-based clinical approaches. Presented at the Symposium on Smoking Cessation at the 29th World Conference of the IUATLD/UICTMR and Global Congress on Lung Health; November 23–26, 1998; Bangkok, Thailand; International Union Against Tuberculosis and Lung Disease. Int J Tuberc Lung Dis.1999; 3: 100–112.
15.
FioreM.C., JorenbyD.E., SchenskyA.E.Smoking status as the new vital sign: effect on assessment and intervention in patients who smoke. Mayo Clin Proc.1995; 70: 209–213.
16.
ThorndikeA.N., RigottiN.A., StaffordR.S.National patterns in the treatment of smokers by physicians. JAMA.1998; 279: 604–608.
17.
GoldsteinM.G., NiauraR., Willey-LessneC.Physicians counseling smokers: a population-based survey of patients’ perceptions of health care provider-delivered smoking cessation interventions. Arch Intern Med.1997; 157: 1313–1319.
18.
Smoking Cessation: Clinical Practice Guideline (No. 18).Rockville, Md: US Dept of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research, Centers for Disease Control and Prevention; 1996. DHHS Publication No. (AHCPR) 96-0892.
19.
FioreM.C., JorenbyD.E., BakerT.B.Smoking cessation: principles and practice based upon the AHCPR Guideline, 1996. Agency for Health Care Policy and Research. Ann Behav Med.1997; 19: 213–219.
20.
CinciripiniP.M., McClureJ.B.Smoking cessation: recent developments in behavioral and pharmacologic interventions. Oncology.1998; 12: 249–256.
21.
HughesJ.R., GoldsteinM.G., HurtR.D.Recent advances in the pharmacotherapy of smoking. JAMA.1999; 281: 72–76.
22.
An Ounce of Prevention: What Are the Returns?2nd ed.Atlanta, Ga: Prevention Effectiveness Branch, Division of Prevention Research and Analytic Methods, Epidemiology Program Office, Centers for Disease Control and Prevention; 1999.
23.
Ossip-KleinD.J., GiovinoG.A., MegahedN.Effects of a smokers’ hotline: results of a 10-county self-help trial. J Consult Clin Psychol.1991; 59: 325–332.
LichtensteinE., GlasgowR.E., LandoH.A.Telephone counseling for smoking cessation: rationales and meta-analytic review of evidence. Health Educ Res.1996; 11: 243–257.
26.
ZhuS.H., StretchV., BalabanisM.Telephone counseling for smoking cessation: effects of single-session and multiple-session interventions. J Consult Clin Psychol.1996; 64: 202–211.
27.
ProchaskaJ.O., DiClementeC.C., VelicerW.F.Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychol.1993; 12: 399–405.
BrandonT.H., CopelandA.L., SaperZ.L.Programmed therapeutic messages as a smoking treatment adjunct: reducing the impact of negative affect. Health Psychol.1995; 14: 41–47.
30.
ZelmanD.C., BrandonT.H., JorenbyD.E.Measures of affect and nicotine dependence predict differential response to smoking cessation treatments. J Consult Clin Psychol.1992; 60: 943–952.
SonderskovJ., OlsenJ., SabroeS.Nicotine patches in smoking cessation: a randomized trial among over-the-counter customers in Denmark. Am J Epidemiol.1997; 145: 309–318.
33.
FioreM.C., SmithS.S., JorenbyD.E.The effectiveness of the nicotine patch for smoking cessation: a meta-analysis. JAMA.1994; 271: 1940–1947.
34.
LeischowS.J., NilssonF., FranzonM.Efficacy of the nicotine inhaler as an adjunct to smoking cessation. Am J Health Behav.1996; 20: 364–371.
35.
SchneiderN.G., OlmsteadR., NilssonF.Efficacy of a nicotine inhaler in smoking cessation: a double-blind, placebo-controlled trial. Addiction.1996; 91: 1293–1306.
36.
TonnesenP., NorregaardJ., MikkelsenK.A double-blind trial of a nicotine inhaler for smoking cessation. JAMA.1993; 269: 1268–1271.
37.
FouldsJ.Nicorette nasal spray: a novel nicotine therapy. Prescriber.1994; 19: 21–25.
38.
BlondalT., FranzonM., WestinA.A double-blind randomized trial of nicotine nasal spray as an aid in smoking cessation. Eur Respir J.1997; 10: 1585–1590.
KornitzerM., BoutsenM., DramaixM.Combined use of nicotine patch and gum in smoking cessation: a placebo controlled clinical trial. Prev Med.1995; 24: 41–47.
41.
BlondalT., GudmundssonL.J., OlafsdottirI.Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. Br Med J.1999; 318: 285–289.
42.
HurtR.D., SachsD.P., GloverE.D.A comparison of sustained-release buproprion and placebo for smoking cessation. N Engl J Med.1997; 337: 1195–1202.
43.
JorenbyD.E., LeischowS.J., NidesM.A.A controlled trial of sustained-release buproprion, a nicotine patch, or both for smoking cessation. N Engl J Med.1999; 340: 685–691.
44.
ProchazkaA.V., WeaverM.J., KellerR.T.A randomized trial of nortriptyline for smoking cessation. Arch Intern Med.1998; 158: 2035–2039.
45.
HallS.M., ReusV.I., MunozR.F.Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking. Arch Gen Psychiatry.1998; 55: 683–690.
46.
GlynnT.J., ManleyM.W., PechacekT.F.Physician-initiated smoking cessation program: the National Cancer Institute trials. Prog Clin Biol Res.1990; 339: 11–25.
47.
GritzE.R., CarrC.R., RapkinD.Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev.1993; 2: 261–270.
48.
CromwellJ., BartoschW.J., FioreM.C.Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA.1997; 278: 1759–1766.
